Farmabios

Axplora Announces €35 Million Expansion at Farmabios

Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new production unit at Gropello Cairoli, Italy, expanding its large scale manufacturing capabilities for high potent active pharmaceutical ingredients (HPAPIs) and steroids.

Topics • Innovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

Top-Feature

Bio-Rad Laboratories

Brenntag Downsizes Management Board, Retains Both Divisions

Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Axplora

Farmabios

Axplora Announces €35 Million Expansion at Farmabios

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

Top-Feature

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Leading the way. Driving results.

Anchored in Sustainability

API Manufacturing

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Leading Transformation

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Driving Sustainability Through Collaboration

Brenntag Downsizes Management Board, Retains Both Divisions

Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition